Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kotecha RR"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
Autorzy:
Rothrock RJ; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.; Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA.
Ozair A; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Avendano MC; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Herrera S; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Appel H; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Ramos S; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Starosciak AK; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Leon-Ariza DS; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Rubens M; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
McDermott MW; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.; Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL, USA.
Ahluwalia MS; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Mehta MP; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Kotecha RR; Office 1R203, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA. .; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 12; Vol. 25 (1), pp. 41. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Spinal Fractures*
Spinal Neoplasms*/radiotherapy
Adult ; Humans ; Spine ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study.
Autorzy:
Tatineni V; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
O'Shea PJ; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Saxena S; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Khosla AA; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Ozair A; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Kotecha RR; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Jia X; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Rauf Y; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Department of Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Division of Neuro-Oncology, University of North Carolina, Chapel Hill, NC 27599, USA.
Murphy ES; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Chao ST; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Suh JH; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Peereboom DM; Rosa Ella Burkhart Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.; Department of Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jun 01; Vol. 15 (11). Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.
Autorzy:
Ozair A; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Faculty of Medicine, King George's Medical University, Lucknow 226003, India.
Bhat V; St. John's Medical College, Bangalore 560034, India.
Alisch RS; Department of Neurosurgery, University of Wisconsin-Madison, Madison, WI 53792, USA.
Khosla AA; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Kotecha RR; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Odia Y; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
McDermott MW; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.; Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Feb 20; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.
Autorzy:
Golkaram M; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Kuo F; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Gupta S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Carlo MI; Department of Medicine, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, NY, 10065, USA.
Salmans ML; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Vijayaraghavan R; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Tang C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Makarov V; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Rappold P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Blum KA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Zhao C; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Mehio R; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Zhang S; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Godsey J; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
Pawlowski T; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
DiNatale RG; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Morris LGT; Department of Surgery, Head & Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Durack J; Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Russo P; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Kotecha RR; Department of Medicine, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, NY, 10065, USA.
Coleman J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Chen YB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Reuter VE; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Motzer RJ; Department of Medicine, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, NY, 10065, USA.
Voss MH; Department of Medicine, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, NY, 10065, USA.
Liu L; Illumina, Inc., 5200 Illumina Way, San Diego, CA, 92122, USA. .
Reznik E; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .; Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .
Chan TA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, 44195, USA. .; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. .; National Center for Regenerative Medicine, Cleveland Clinic, Cleveland, OH, 44195, USA. .
Hakimi AA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2022 Dec 19; Vol. 14 (1), pp. 143. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Carcinoma, Renal Cell*/genetics
Carcinoma*
Kidney Neoplasms*/genetics
Humans ; Nivolumab ; Pilot Projects ; T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Optimizing the radiotherapy treatment planning process for glioblastoma.
Autorzy:
Kotecha RR; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Jun 21; Vol. 9 (5), pp. 351-353. Date of Electronic Publication: 2022 Jun 21 (Print Publication: 2022).
Typ publikacji:
Editorial
Opinia redakcyjna
Tytuł:
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.
Autorzy:
Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Tonse R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Appel H; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Odia Y; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.; Department of Neuro Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Kotecha RR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Rabinowits G; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.; Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Apr 18; Vol. 28 (2), pp. 1537-1543. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji:
Case Reports
MeSH Terms:
Meningeal Neoplasms*/drug therapy
Meningioma*/drug therapy
Anilides/therapeutic use ; Humans ; Neoplasm Recurrence, Local ; Pyridines
Raport
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies